School of Medicine
Showing 3,591-3,600 of 5,024 Results
-
Benjamin Micah Raber
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Benjamin Raber is a board-certified, fellowship-trained surgical oncologist at Stanford Health Care. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Raber specializes in surgical treatments for benign and cancerous breast diseases. He performs a wide range of procedures, including lumpectomy, nipple-sparing mastectomy, and preventive mastectomy. Dr. Raber uses the latest and most effective surgical approaches, including wire-free, breast-conserving surgery for lumpectomies and hidden scar surgery (to hide incisions). He is committed to compassionate, patient-centered care that involves close collaboration with his colleagues in medical and radiation oncology, radiology, and plastic surgery.
Dr. Raber is actively involved in community outreach and breast cancer education. He has led regional initiatives to promote awareness, expand access to breast cancer screenings, and improve early detection.
Dr. Raber’s research focuses on improving surgical treatments for breast cancer, including better ways to treat cancer that has spread to nearby lymph nodes. He has also explored using ultrasound imaging to help surgeons locate and remove cancerous tissue more precisely during breast-conserving surgery. His research has been published in prominent peer-reviewed journals, including Annals of Surgical Oncology, Magnetic Resonance Imaging Clinics of North America, and The American Journal of Surgery.
Dr. Raber is a fellow of the American College of Surgeons (ACS) and a member of the American Society of Breast Surgeons (ASBrS). -
Marlene Rabinovitch
Dwight and Vera Dunlevie Professor of Pediatric Cardiology
Current Research and Scholarly InterestsOur research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.
-
Ralph Rabkin
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsDr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease.
-
Thomas Raffin
The Colleen and Robert Haas Professor in Medicine and Biomedical Ethics, Emeritus
Current Research and Scholarly InterestsDr. Raffin is a clinician, teacher and investigator. He retired as Chief of the Division of Pulmonary and Critical Care Medicine in 2004. His key areas of academic interest include the biology and management of acute lung injury; basic biology of human lung and white cells; and, key issues in biomedical ethics including withholding and withdrawing life support, health care delivery, genomics, genetic screening, and neuroethics.
-
Nilima Ragavan
Clinical Professor, Pediatrics - Neonatology
BioDr Nilima Ragavan is a Neonatologist and Clinical Professor at the Stanford University School of Medicine. She is an experienced clinician who has expertise in the care of critically ill newborns.She is the Neonatal Outreach Medical director for Stanford Children's health, Co director of the Mid Coastal California Perinatal Outreach Program, and the Medical director of the Special care Nursery at Stanford Children's Health.She serves as a mentor to junior faculty. Dr Ragavan is passionate about education, and social justice. She has worked in and promoted social organizations in the fields of education, health care, livelihood and women's empowerment in India.She founded a group called Teach to Heal to promote cross cultural education and has led several multidisciplinary medical teams to India, as well as organized and conducted international neonatal and perinatal conferences.
-
Amer Raheemullah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Amer Raheemullah, MD, is Associate Clinical Professor of Psychiatry and Behavioral Sciences at Stanford University. He is the Director of Stanford Hospital Addiction Services (shas.stanford.edu), which he initially launched at a single site, and after demonstrating significant improvements in patient outcomes, led its expansion across Stanford’s multiple hospital sites.
His research and insights on habits and addictive behavior have been published in leading journals including JAMA and Cambridge University Press, and has been featured in media outlets such as Bloomberg News, ABC7 News, KQED, and Everyday Health. He has been invited to advise on national addiction policy by the U.S. Food and Drug Administration (FDA), the U.S. Department of Health and Human Services (HHS), the Substance Abuse and Mental Health Services Administration (SAMHSA), as well as the Congress-established Reagan-Udall Foundation. He has also consulted for several Silicon Valley digital health startups focused on habits and addictive behaviors, such as Lucid Lane, where he led the development and expansion of clinical programs that enabled the organization to grow from a single-state initiative into a nationally operating program within a few years.
His academic work focuses on translating research into scalable models of addiction treatment that can be integrated into health care systems, digital health interventions, and public policy to expand access to high-quality, evidence-based care. Since completing his addiction medicine training at Stanford University School of Medicine, he has continued to work directly with patients across a wide range of settings, including community-based programs, sober living environments, outpatient clinics, residential treatment facilities, inpatient units, and correctional settings. -
Ehsan Rahimy
Adjunct Clinical Associate Professor, Ophthalmology
BioDr. Ehsan Rahimy specializes in the medical and surgical management of diseases affecting the retina, with a clinical expertise in macular degeneration, diabetic retinopathy, retinal detachment, macular hole, macular pucker/epiretinal membranes, and uveitis.
Dr. Rahimy has authored well over 100 peer-reviewed publications, numerous book chapters, as well as other non-peer reviewed literature. He presents regularly at national and international ophthalmic meetings, having contributed over 200 conference abstracts.
He is passionate about the interplay between technology and medicine, and how ongoing advancements will transform healthcare delivery in the near future. Dr. Rahimy is frequently consulted for collaborative research endeavors and advises on numerous early stage companies involved in ophthalmology, telemedicine, A.I., and other medtech innovation.
Dr. Rahimy graduated with highest distinction from the University of Michigan, followed by receiving his medical degree, with high honors, at Baylor College of Medicine. During this time, he was one of a select few junior inductees into the Alpha Omega Alpha (AOA) Honor Society. He went on to complete his ophthalmology residency at the world-renowned Jules Stein Eye Institute at UCLA, recognized as one of the premier residency programs in the country, where he received the Pepose-Saltzman Young Investigator Research Award, Henry & Lilian Nesburn Research Award, and the Devgan Outstanding Surgical Resident Award. Afterwards, he pursued subspecialty training in vitreoretinal surgery at Wills Eye Hospital, considered the preeminent retinal fellowship program in the country, under the guidance and mentorship of many of the field's leaders. While there, he was awarded a Heed Fellowship, the Ronald G. Michels Fellowship Award, and the William B. Tasman Outstanding Fellow Award. -
Elham Rahimy, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Rahimy is a radiation oncologist who treats patients with brain, spine, gastrointestinal, and metastatic tumors. She received her medical training at Yale, followed by residency at Stanford. She is a Clinical Assistant Professor with the Stanford Department of Radiation Oncology.
Dr. Rahimy's technical expertise includes CyberKnife Radiosurgery and MRI-guided adaptive planning. She is also actively involved in radiation oncology research and clinical trials. Her interests include improving patient and resident education, and enhancing patient quality of life and survivorship. She leads quality initiatives as a Quality Physician Improvement Leader, and serves as the Medical Student Clerkship Director. -
Afrin Kamal Rahman MD MS
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioDr. Afrin Kamal Rahman (previously known as Dr. Kamal) is a Clinical Associate Professor of Gastroenterology at Stanford University School of Medicine. Her health services research interests focus on developing and testing communication tools to improve the patient-care provider experience. She has authored 50+ peer reviewed publications and is an NIH funded research. Dr. Rahman is a principal investigator for a K23 grant awarded by the NIDDK to develop and test a mobile health application tool for patients with gastroesophageal reflux disease (GERD).
Dr. Rahman is co-chair of the Young International Society for Diseases of the Esophagus (ISDE) and serves on several committees as part of American College of Gastroenterology and American Foregut Society. She is also an associate editor for Diseases of the Esophagus and director of the Esophageal Virtual Collaborative, an on-line platform with a mission to discuss complex challenging cases in benign esophageal disease among colleagues cross-nation.
PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=kamal%2C+afrin&sort=date
Research website: knowreflux.org
